1. Home
  2. NNN vs STVN Comparison

NNN vs STVN Comparison

Compare NNN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NNN REIT Inc.

NNN

NNN REIT Inc.

HOLD

Current Price

$42.19

Market Cap

7.8B

Sector

Real Estate

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$19.25

Market Cap

5.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNN
STVN
Founded
1984
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Containers/Packaging
Sector
Real Estate
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
5.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NNN
STVN
Price
$42.19
$19.25
Analyst Decision
Hold
Hold
Analyst Count
7
2
Target Price
$43.17
$23.75
AVG Volume (30 Days)
1.4M
351.9K
Earning Date
02-11-2026
03-05-2026
Dividend Yield
5.62%
0.32%
EPS Growth
N/A
19.61
EPS
2.08
0.60
Revenue
$906,297,000.00
$1,373,219,524.00
Revenue This Year
$6.08
$8.42
Revenue Next Year
$4.94
$9.61
P/E Ratio
$20.54
$32.52
Revenue Growth
4.53
6.97
52 Week Low
$35.80
$17.81
52 Week High
$44.23
$28.00

Technical Indicators

Market Signals
Indicator
NNN
STVN
Relative Strength Index (RSI) 63.08 36.02
Support Level $40.29 $18.80
Resistance Level $42.93 $21.23
Average True Range (ATR) 0.64 0.80
MACD 0.23 -0.14
Stochastic Oscillator 78.49 11.09

Price Performance

Historical Comparison
NNN
STVN

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: